Snyder; Linda A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Snyder; Linda A..The latest application filed is for "methods of treating prostate cancer".
- Snyder; Linda A. - Pottstown PA
- Snyder; Linda A - Pottstown PA
- Snyder; Linda A. - Radnor PA
| Patent | Date |
|---|---|
| Methods of Treating Prostate Cancer App 20220071979 - Gottardis; Marco ; et al. | 2022-03-10 |
| Methods of Treating Prostate Cancer App 20220071980 - Gottardis; Marco ; et al. | 2022-03-10 |
| Method of treating prostate cancer Grant 11,207,311 - Gottardis , et al. December 28, 2 | 2021-12-28 |
| Anti-Vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same App 20210347896 - Snyder; Linda A. ; et al. | 2021-11-11 |
| Anti-vista Antibodies And Fragments App 20210318322 - Snyder; Linda A. ; et al. | 2021-10-14 |
| Anti-vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same App 20210171640 - Snyder; Linda A. ; et al. | 2021-06-10 |
| Anti-vista antibodies and fragments, uses thereof, and methods of identifying same Grant 11,014,987 - Snyder , et al. May 25, 2 | 2021-05-25 |
| Anti-VISTA antibodies and fragments Grant 11,009,509 - Snyder , et al. May 18, 2 | 2021-05-18 |
| Method of identifying anti-VISTA antibodies Grant 10,899,836 - Snyder , et al. January 26, 2 | 2021-01-26 |
| Method Of Treating Prostate Cancer App 20190022079 - Gottardis; Marco ; et al. | 2019-01-24 |
| Anti-VISTA Antibodies And Fragments App 20180306799 - Snyder; Linda A. ; et al. | 2018-10-25 |
| Methods of Treating Prostate Cancer App 20180028521 - Gottardis; Marco ; et al. | 2018-02-01 |
| Anti-Vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same App 20170320950 - Snyder; Linda A. ; et al. | 2017-11-09 |
| Anti-vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same App 20170233479 - Snyder; Linda A. ; et al. | 2017-08-17 |
| Anti-alpha V immunoliposome compositions, methods and uses Grant 8,138,315 - Goldstein , et al. March 20, 2 | 2012-03-20 |
| Anti-alpha V Immunoliposome Compositions, Methods And Uses App 20110268655 - Goldstein; Joshua ; et al. | 2011-11-03 |
| Cynomolgus prostate specific antigen Grant 7,666,993 - Marshall , et al. February 23, 2 | 2010-02-23 |
| Anti-Alpha-V Immunoliposome Composition, Methods, and Uses App 20090196913 - Huang; Ken Shi Kun ; et al. | 2009-08-06 |
| Anti-Alpha V Immunoliposome Composition, Methods, and Uses App 20090175784 - Goldstein; Joshua ; et al. | 2009-07-09 |
| Cynomolgus Prostate Specific Antigen App 20090118468 - Marshall; Deborah J. ; et al. | 2009-05-07 |
| Cynomolgus prostate specific antigen Grant 7,342,107 - Marshall , et al. March 11, 2 | 2008-03-11 |
| Method for screening agents against human prostate disease App 20050276758 - Marshall, Deborah J. ; et al. | 2005-12-15 |
| Cynomolgus prostate specific antigen App 20050266530 - Marshall, Deborah J. ; et al. | 2005-12-01 |
| Nucleic acid compositions and methods for use App 20050261213 - Branigan, Patrick ; et al. | 2005-11-24 |
| Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses App 20040023336 - Heavner, George A. ; et al. | 2004-02-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 